| | Sensitivity | | |
---|
| Specificity (n = 171) | One viable cyst (n = 26) | Two or more viable cysts (n = 77) | Calcified cysts (n = 46) |
---|
| (+/−) | Sp (%) | (+/−) | S (%) | (+/−) | S (%) | (+/−) | S (%) |
---|
T24H-his | 1/170 | 99.4 | 23/3 | 88.5 | 77/0 | 100 | 38/8 | 82.6 |
GST-Ts8B2 | 2/169 | 98.8 | 19/7 | 73.1 | 68/9 | 88.3 | 16/30 | 34.8 |
GST-T24H | 0/171 | 100 | 21/5 | 80.8 | 74/3 | 96.1 | 37/9 | 80.4 |
LLGP | | | 22/4 | 84.6 | 75/2 | 97.4 | 32/11b
| 74.4 |
- A Chi-square test (χ
2) carried out for each antigen, with degrees of freedom (df) equal to 1 and significance level (P) P < 0.05. T24H-his: χ
2 = 274.488, df = 1, P < 0.001; GST-Ts8B2: χ
2 = 169.289, df = 1, P < 0.001; GST-T24H, χ
2 = 257.855, df = 1, P < 0.001
-
Abbreviations: n number of sera in each group, +/− number of positive and negative sera obtained in each case, Sp (%) specificity percentage obtained with each antigen in western blot, S (%) sensitivity percentage for each antigen in each NCC group
-
aSensitivity was determined according to viability and number of cysticerci in neurocysticercosis (NCC) patients
-
bJust 43 samples from patients with calcified cysts were tested in LLGP-EITB